Company profile
Endomag | Revolutionizing Breast Cancer Surgery
All-in-one breast cancer localization and staging technology designed to improve patient outcomes, prevent unnecessary surgery and transform global breast cancer care.y
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUxMjU0ODExN2FkaXF6a2N4
Published 25 Mar 2026 14:55
Last confirmation statement made up date
Last accounts made up date
RESOLUTIONS | Transaction WURFWUc0SkRhZGlxemtjeA | Paper/PDF filed
Published 13 Nov 2024 07:50
MA | Transaction MzQ0MTc3OTg1N2FkaXF6a2N4 | Paper/PDF filed
Published 13 Nov 2024 07:50
SH10 | Transaction MzQ0MTc3OTgzMWFkaXF6a2N4 | Paper/PDF filed
Published 05 Nov 2024 07:32
SH08 | Transaction MzQ0MTc3OTgxM2FkaXF6a2N4 | Paper/PDF filed
Published 05 Nov 2024 07:27
PSC02 | Transaction MzQzNjY4MjMwOWFkaXF6a2N4
Published 20 Sep 2024 11:40
PSC09 | Transaction MzQzNjY4MTMyOWFkaXF6a2N4
Published 20 Sep 2024 11:01
RESOLUTIONS | Transaction QUQ4SUVCTlZhZGlxemtjeA | Paper/PDF filed
Published 08 Aug 2024 10:10
MA | Transaction MzQzMTYwMDMwN2FkaXF6a2N4 | Paper/PDF filed
Published 08 Aug 2024 10:04
MA | Transaction MzQzMTYwMDMwNmFkaXF6a2N4 | Paper/PDF filed
Published 08 Aug 2024 10:03
ANNOTATION | Transaction MzQzMTI3OTkwNGFkaXF6a2N4 | Paper/PDF filed
Published 27 Aug 2024 15:52
Company registered at Companies House
1 Jan 2013 to 31 Dec 2013
The novel SentiMag magnetic dye and hand-held magnetometer technique has been successfully applied to the sentinel lymph node biopsy (SLNB) procedure in breast cancer. It overcomes the disadvantages of the current radioisotope based technique - including lack of availability, workflow and handling issues and exposure to radiation. The benefits of this mag...
1 Oct 2012 to 31 Dec 2013
Around the world the increasing prevalence of breast cancer screening means that cancers are more often being detected at an early stage when they are only visible under imaging and cannot otherwise be located. In these cases, the surgeon requires a guide marker to locate the tumour to be removed. The current ‘gold standard’ for removing such 'non-palpabl...
1 Dec 2008 to 30 Nov 2010
Awaiting Public Summary
